ReviewExpert opinion on therapeutic targets2022

Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape.

Xuemei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.